WASHINGTON, April 13 (Reuters) - The Trump administration is considering appointing Houman Hemmati, an ophthalmologist and a frequent Fox News guest, to lead the FDA's Center for Biologics Evaluation ...

How do humans make decisions? The question has been on Uri Maoz’s mind since he read an article in his early twenties suggesting that… maybe they didn’t.   Had he even had a choice about whether to ...

Many Americans have a soft spot for the Make America Healthy Again movement — even if they can't name many of its pivotal figures. It shocked the public health establishment when President Donald ...

Chef Donatello Montrone is clear about one thing: Moderna is not trying to be trendy. It is not a gimmicky fusion concept, and it is not Italian food chasing novelty. Instead, the newly opened ...

The health ministry is preparing to recommend males in their teens and 20s get the Pfizer COVID-19 vaccine instead of Moderna ...

Co-founder of more than 40 biotechnology companies, including 16 IPOs and 19 successful acquisitions Scientific and medical titan focused on driving innovation for human healthWill assist with ...

Replimune has had its advanced melanoma treatment RP1 turned down by the FDA for a second time, a decision that has led the company to accuse the agency of inconsistencies in its review of the drug.

View Arbutus Biopharma Corporation ABUS stock quote prices, financial information, real-time forecasts, and company news from CNN.